chenodeoxycholic acid has been researched along with Benign Mastocytoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jun, EJ; Jung, SM; Kim, JK; Kim, KH; Kim, ND; Lee, S; Lim, YJ; Park, BS; Seo, SY; Suh, H; Yoo, YH | 1 |
1 other study(ies) available for chenodeoxycholic acid and Benign Mastocytoma
Article | Year |
---|---|
Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Chenodeoxycholic Acid; Cysteine Endopeptidases; DNA Fragmentation; Drug Synergism; Mastocytoma; Membrane Potentials; Mice; Mitochondria; Multienzyme Complexes; Poly(ADP-ribose) Polymerases; Proteasome Endopeptidase Complex | 2003 |